DY
LCTX icon

Dowling & Yahnke’s Lineage Cell Therapeutics LCTX Stock Holding History

Dowling & Yahnke’s Portfolio LCTX Stock Details LCTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		$36K Hold
32,263
– – ﹤0.01% 371
2022
Q2 		$51K Buy
+32,263
New +$51K ﹤0.01% 370